JP2022544308A5 - - Google Patents
Info
- Publication number
- JP2022544308A5 JP2022544308A5 JP2022509040A JP2022509040A JP2022544308A5 JP 2022544308 A5 JP2022544308 A5 JP 2022544308A5 JP 2022509040 A JP2022509040 A JP 2022509040A JP 2022509040 A JP2022509040 A JP 2022509040A JP 2022544308 A5 JP2022544308 A5 JP 2022544308A5
- Authority
- JP
- Japan
- Prior art keywords
- lrp5
- seq
- antibody
- cdr
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962886913P | 2019-08-14 | 2019-08-14 | |
| US62/886,913 | 2019-08-14 | ||
| PCT/CA2020/051119 WO2021026665A1 (en) | 2019-08-14 | 2020-08-14 | Antibodies that bind to lrp5 proteins and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544308A JP2022544308A (ja) | 2022-10-17 |
| JP2022544308A5 true JP2022544308A5 (https=) | 2023-08-21 |
| JP7840842B2 JP7840842B2 (ja) | 2026-04-06 |
Family
ID=74570326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509040A Active JP7840842B2 (ja) | 2019-08-14 | 2020-08-14 | Ｌｒｐ５タンパク質に結合する抗体および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230183336A1 (https=) |
| EP (1) | EP4013791A4 (https=) |
| JP (1) | JP7840842B2 (https=) |
| KR (1) | KR20220078568A (https=) |
| CN (2) | CN119798435A (https=) |
| AU (1) | AU2020329092A1 (https=) |
| CA (1) | CA3147827A1 (https=) |
| IL (1) | IL290509A (https=) |
| MX (1) | MX2022001947A (https=) |
| WO (1) | WO2021026665A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023250402A2 (en) * | 2022-06-22 | 2023-12-28 | Antlera Therapeutics Inc. | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
| WO2022212429A1 (en) * | 2021-03-31 | 2022-10-06 | Sachdev Sidhu | Anti-viral compositions for rift valley fever virus infections and methods of using same |
| EP4547713A2 (en) * | 2022-06-30 | 2025-05-07 | The University of Chicago | Cd73 (nt5e) targeting polypeptides |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004261980A1 (en) * | 2003-08-01 | 2005-02-10 | Genentech, Inc. | Antibody CDR polypeptide sequences with restricted diversity |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| US8790650B2 (en) * | 2011-04-28 | 2014-07-29 | Vanderbilt University | Methods of using an antibody to inhibit WNT-mediated cardiac remodeling |
| US9200072B2 (en) * | 2012-01-18 | 2015-12-01 | Genentech Inc. | Anti-LRP5 antibodies and methods of use |
| US20190194314A1 (en) * | 2012-12-21 | 2019-06-27 | Stowers Institute For Medical Research | Antibodies for modulating binding between lrp and wise |
| US10294294B2 (en) * | 2015-09-10 | 2019-05-21 | Albert Einstein College Of Medicine | Synthetic antibodies to BAX and uses thereof |
| UA122079C2 (uk) * | 2015-12-04 | 2020-09-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Поліпептид, що специфічно зв'язується з lrp5 і lrp6 |
| CA3077518C (en) * | 2016-09-07 | 2021-10-19 | Frederic Fellouse | Synthetic antibodies against vegf and their uses |
| EP3630816B1 (en) * | 2017-05-31 | 2024-03-20 | Boehringer Ingelheim International GmbH | Polypeptides antagonizing wnt signaling in tumor cells |
| EP3700930A1 (en) * | 2017-10-25 | 2020-09-02 | The Regents of the University of California | Antibodies against cdcp1 for the treatment and detection of cancer |
| CA3080120C (en) * | 2017-10-27 | 2023-11-21 | New York University | Anti-galectin-9 antibodies and uses thereof |
| CN111699003B (zh) | 2017-12-19 | 2024-05-03 | 瑟罗泽恩奥普瑞汀公司 | 抗lrp5/6抗体和使用方法 |
| JP7550647B2 (ja) * | 2018-02-14 | 2024-09-20 | アントレラ セラピューティクス インコーポレイテッド | Ｗｎｔシグナル伝達を活性化する多価結合分子およびその使用 |
| US10640562B2 (en) * | 2018-07-17 | 2020-05-05 | Mcmaster University | T cell-antigen coupler with various construct optimizations |
| CA3111087A1 (en) * | 2018-08-29 | 2020-03-05 | Nanjing Legend Biotech Co., Ltd. | Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof |
-
2020
- 2020-08-14 JP JP2022509040A patent/JP7840842B2/ja active Active
- 2020-08-14 CN CN202411353225.5A patent/CN119798435A/zh active Pending
- 2020-08-14 WO PCT/CA2020/051119 patent/WO2021026665A1/en not_active Ceased
- 2020-08-14 KR KR1020227008528A patent/KR20220078568A/ko active Pending
- 2020-08-14 CA CA3147827A patent/CA3147827A1/en active Pending
- 2020-08-14 CN CN202080072086.2A patent/CN114599679B/zh active Active
- 2020-08-14 MX MX2022001947A patent/MX2022001947A/es unknown
- 2020-08-14 EP EP20851713.6A patent/EP4013791A4/en active Pending
- 2020-08-14 US US17/634,901 patent/US20230183336A1/en active Pending
- 2020-08-14 AU AU2020329092A patent/AU2020329092A1/en active Pending
-
2022
- 2022-02-10 IL IL290509A patent/IL290509A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8637017B2 (en) | Anti-EpCAM antibodies | |
| JP2023002562A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2026041845A5 (https=) | ||
| HRP20190605T1 (hr) | Protutijela anti-fxi i postupci njihove uporabe | |
| JP2019513018A5 (https=) | ||
| JP2017519759A5 (https=) | ||
| JP2022544308A5 (https=) | ||
| RU2018124319A (ru) | Новые антитела к клаудину и способы их применения | |
| JP2024538669A5 (https=) | ||
| CN115605511A (zh) | 抗tigit的抗体、其制备方法和应用 | |
| JP2024153733A5 (https=) | ||
| JP2019507580A5 (https=) | ||
| JP2019505166A5 (https=) | ||
| IL276675B2 (en) | Anti-PD-1 antibodies and uses thereof | |
| JP2021512604A5 (https=) | ||
| JP2024536881A5 (https=) | ||
| JP2023528416A5 (https=) | ||
| JP2024517953A5 (https=) | ||
| JP2025510642A5 (https=) | ||
| JP2022544307A5 (https=) | ||
| JP2024532836A5 (https=) | ||
| CN114829405B (zh) | 抗bcma/抗4-1bb双特异性抗体及其用途 | |
| JP2025503229A5 (https=) | ||
| AU2019306113B2 (en) | Anti-human PD-L1 antibodies and their uses |